Your browser doesn't support javascript.
Tranexamic acid is safe to use following mild-to-moderate traumatic brain injury.
BMJ ; 368: m514, 2020 03 11.
Artículo en Inglés | MEDLINE | ID: mdl-32161036
ABSTRACT
The studyThe CRASH-3 Trial Collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3) a randomised, placebo-controlled trial. Lancet 2019;3941713-23.This trial was funded by NIHR Health Technology Assessment Programme (project number 14/190/01), JP Moulton Charitable Trust, Department of Health and Social Care, Department for International Development, Global Challenges Research Fund, Medical Research Council, and the Wellcome Trust (Joint Global Health Trials scheme).To read the full NIHR Signal, go to https//discover.dc.nihr.ac.uk/content/signal-000870/tranexamic-acid-following-mild-to-moderate-traumatic-brain-injury-is-safe-and-reduces-deaths.
Asunto(s)

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Enfermedades Vasculares / Lesiones Traumáticas del Encéfalo / Antifibrinolíticos Tipo de estudio: Ensayo clínico controlado / Evaluación de tecnologías sanitárias Límite: Humanos Idioma: Inglés Revista: BMJ Asunto de la revista: Medicina Año: 2020 Tipo del documento: Artículo País de afiliación: Reino Unido